ARCHIVES

FDA developing guidelines for oncology endpoints.

This article is from The Cancer Letter archive.

Vol. 30 No. 19 | May 7, 2004

Download PDF Visit The Full Archive

Related Articles

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

John Niederhuber Named Acting NCI Director.

June 2, 2006

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

December 7, 1990

NCI To Ask HCFA to Launch Pilot Clinical Trials Program

March 22, 1996

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

March 1, 2013

Skin Cancer Screens Find “Extraordinary High” Rates

September 20, 1985